Introduction
Cytochrome P450 (P450) constitutes a superfamily of enzymes which activate dioxygen and carry out monooxygenation reactions of large numbers of endogenous and xenobiotic compounds. [1] [2] [3] [4] These include xenobiotic substances such as drugs with many new drugs produced by the pharmaceutical companies, procarcinogens, antioxidants, alcohols, organic solvents, and plant products, as well as physiologically essential organic compounds such as fatty acids, steroids, eicosanoids, lipid hydroperoxides, retinoids, and amino acids. 5, 6) Recent progress in P450 research in many laboratories has revealed the occurrence of numerous P450 isoforms that catalyze a large number of reactions across diŠerent species. [7] [8] [9] Drug metabolism is a particularly important P450 function because many drugs either undergo oxidative inactivation and detoxiˆcation or are activated to yield toxic or carcinogenic products by the microsomal P450s in the liver. Therefore, elucidating the metabolic products and pathways of drugs, including new drugs which are mediated by mammalian P450s, especially by human microsomal P450s, is essential for drug develop-ment. However, many factors involved in understanding the mechanisms responsible for the very broad substrate speciˆcity of microsomal P450s and for the remarkably narrow positional and stereochemical speciˆcity of catalyzed reactions remain unclear. In order to explain the substrate selectivity of P450, there is persuasive evidence that it is necessary to clarify the detailed structure of P450s, 10, 11) which is as yet unknown for the mammalian P450 isoforms except for CYP2C5, 12) and there is additional evidence that it is necessary to demonstrate the occurrence of multiple activated oxygen species to determine the type of catalyzed reactions. [13] [14] [15] [16] A mechanism for the P450-dependent catalytic cycle to activate dioxygen has been proposed and accepted by many researchers. 5, [17] [18] [19] [20] In this mechanism, a hypervalent iron-oxene species, that is, an oxo-Fe(IV)-porphyrin-p-cation radical, is widely considered to be an oxidant as activated oxygen intermediate in P450-catalyzed reactions. 21, 22) This concept of the oxidant has developed in part from the well-recognized chemical properties of peroxidase 23) and iron-porphyrin model compounds. 24) However, a nucleophilic ironperoxo species was also proposed as another oxidant in the demethylation of androgens by P450arom, aromatase, to give estrogens. 13, 25) In addition, puriˆed liver microsomal P450s were recently found to produce a comparable metabolite, the oxidative deformation of various xenobiotic aldehydes, to oleˆns and formate. [26] [27] [28] In the past decade, various studies have indicated that P450-catalyzed oxygenations are complex, and that a single reaction pathway cannot explain all of the experimental results.
P450-catalyzed oxygenations typically require the input of two electrons that are transferred to P450 either by the ‰avoprotein NADH-putidaredoxin in the bacterial system or by the ‰avoprotein NADPH-cytochrome P450 reductase in the mammalian microsomal system. 29) The microsomal system also contains cytochrome b5, which is a small membrane-bound hemoprotein, and its NADH-dependent reductase. Although cytochrome b 5 acts as an alternative source of electrons for the microsomal P450, it appears to be much less eŠective than the NADPH-P450 reductase, and its role in the P450 function remains unclear.
30) The e‹ciency of electron transfer from NADPH through the electron carriers to P450 for oxygenation reactions is called the degree of coupling. In comparison with soluble protoplasmic microbial monooxygenase systems, the membranous microsomal P450 in eukaryotes are ine‹cient and poorly coupled. 31) Although the degree of coupling of NADPH consumption to drug oxygenation varies dependently on diŠerent P450 isoforms, it is usually less than 50z, [32] [33] [34] and is as low as 0.5-3z in some cases. 35) Due to such uncoupling, the rate of NADPH and dioxygen consumption by the P450 reactions is very weakly dependent on the presence of substrates, and then the microsomal P450 system generates reactive oxygen species (ROS) such as the superoxide anion radical (･O2 -), [36] [37] [38] [39] hydrogen peroxide (H2O2), 36, 37) hydroxyl radical (･OH), 38, 39) and singlet oxygen ( 1 O2). [40] [41] [42] Even in the absence of substrates, the microsomal electron transfer chain continues to oxidize NADPH and produce ROS. Several authors have reported the contribution of ROS in the NADPHdependent substrate oxidations and hepatic lipid peroxidations in microsomal systems. [43] [44] [45] However, the contribution of ROS generation in P450-dependent substrate reactions remains unclear.
During our investigations of P450-catalyzed oxygenetions, 46, 47) we recently found that a potent 1 O2 quencher, b-carotene, suppressed both several P450-dependent reactions in the rat liver microsomes and four enzyme activities in the human CYP subfamily, in which 1 O2 was involved, as conˆrmed by the ESR spintrapping method. 48, 49) Following our previous study, we have continued to examine whether or not the involvement of 1 O2 in the P450-dependent catalytic cycle is a general reaction for other types of oxygenations. 50) In this review, we describe the recent studies concerning the multiple ROS in cytochrome P450 reactions related to drug metabolism that involve the possibility of 1 O2 as an oxidant in the P450 catalytic cycle.
Catalytic Cycle of P450 and Its Mechanism of Oxygen Activation
Studies on the mechanistic details of microsomal P450-dependent reactions and on the bacterial system have led to the establishment of a P450-catalytic scheme for drug metabolism, as shown in Fig. 1 . 5, [17] [18] [19] [20] 51, 52) The steps are in accordance with the stoichiometry of such reactions and are as follows: (1) drug (substrate) binding followed by the conformational change of the P450 molecule, (2)ˆrst electron transfer by the NADPHdependent P450 reductase and reduction of hemeFe(III) to heme-Fe(II), (3) dioxygen binding to hemeFe(II), (4) second electron transfer by the NADPH-P450 reductase or cytochrome b5, (5) protonation of the peroxo-
second protonation and splitting of the dioxygen bond with the generation of iron-oxene, an oxo-Fe(IV)-porphyrin-p-cation radical, and (7) oxygen insertion into the drug (substrate) and the metabolite (product) dissociation from P450 molecule. 5, [17] [18] [19] [20] 51, 52) In step 3 described above, the involvement of ･O 5, 18, 42) In step 4, a second reduction gives the peroxo-Fe(III) intermediate where dioxygen is in the formal oxidation state of hydrogen peroxide. In step 5, protonation of the peroxo-Fe(III) intermediate on the distal oxygen gives the hydroperoxo-Fe(III) intermediate. In step 6, a second protonation on the distal oxygen with a subsequent or concomitant loss of water gives the oxo-Fe(IV)-porphyrin-p-cation radical as the consensus oxidant species. Alternatively, protonation of the hydroperoxo-Fe(III) intermediate on the proximal oxygen gives Fe(III)-complexed H2O2, which can dissociate. The latter reaction is reversible, and the P450s can be shunted with H2O2 to form an activated oxidant. 5, [17] [18] [19] [20] The camphor-hydroxylating cytochrome P450cam (CYP101) from the soil bacterium Pseudomonas putida is the best-studied P450, and thus is regarded to be a model protein for a large number of other P450s. It is assumed that during the P450 reaction cycle the oxo-Fe(IV)-porphyrin-p-cation radical is formed. 21, 22) Recent cryogenic studies in which reduction was accomplished radiolytically succeeded in the ESR detection of the peroxo-Fe(III) and hydroperoxo-Fe(III) species for P450cam. 53, 54) However, the oxo-Fe(IV)-porphyrin-p-cation radical could not be detected by ESR, apparently due to its high reactivity, 53, 54) and thus its identiˆcation in transient X-ray crystallography was uncertain for P450cam. 55) Subsequently in 2002, the formation and breakdown of the oxo-Fe(IV)-porphyrin-p-cation radical were analyzed in the reaction of CYP119, a P450 from thermophilic bacterium Sulfolobus solfataricus, with meta-chloroperoxybenzoic acid (m-CPBA), in which by rapid mixing of m-CPBA with the ferric form of CYP119, a spectral feature characteristic for an oxo-Fe(IV)-porphyrin-p-cation radical was clearly observed in stopped-‰ow studies and identiˆed by the absorption maxima. 22) Because it could be expected that freeze-quenching the intermediate and analyzing the electronic structure by ESR would prove the nature of the oxo-Fe(IV)-porphyrin-p-cation radical, a multifrequency ESR study was recently examined to detect the ESR signal of the oxo-Fe(IV)-porphyrin-pcation radical for P450cam. 56) However, no ESR signal of a porphyrin-p-cation radical was observed, and a transient organic radical due to a tyrosine radical was instead detected, suggesting that an intramolecular electron transfer from a tyrosine of protein residue to the heme may quench the porphyrin-p-cation radical. 56) If this intramolecular electron transfer from a tyrosine near the heme can generally occur in P450s, it will be a possible competitive reaction to the decay of the oxoFe(IV)-porphyrin-p-cation radical via substrate hydroxylation. Thus, it remains controversial whether or not the oxo-Fe(IV)-porphyrin-p-cation radical is a primary oxidant for all P450s molecules.
Multiple Activated Oxygen Species in P450 Catalysis
Excellent studies using the point mutation technique with the bacterial and liver microsomal P450s have recently provided important newˆndings on the details of proton transfer and other functional species of activated oxygen intermediates. As already described, a two-electron reduction of molecular dioxygen produces the peroxo-Fe(III) intermediate, which yields the hydroperoxo-Fe(III) intermediate by protonation. Then, a second proton transfer would lead irreversibly to the oxo-Fe(IV)-porphyrin-p-cation radical and water, or alternatively to free H2O2 and back to the Fe(III)-enzyme represented by theˆve-coordinated high-spin form. Both the crystal structures and sequence alignments of bacterial P450s such as P450cam, 57) P450BM-3, 58) P450terp, 59) and P450eryF, 60) revealed a highly conserved threonine in the helix at the oxygenbinding pocket and within the hydrogen bonding distance of the peroxo-Fe(III) complex. Interestingly, the camphor hydroxylation with the P450cam was demonstrated to signiˆcantly decrease by means of mutation of this residue to alanine, 61, 62) and similar results were obtained from the fatty acid hydroxylation with the P450BM-3. 63, 64) The observed eŠects were attributed to an interference in the proton transfer to the active site of P450s. Then, in terms of the point mutation of this essential threonine residue to alanine in the microsomal P450, the eŠect on drug metabolism was examined in between CYP2B4 (phenobarbital-inducible) and its mutant, CYP2B4 T302A. 65) The results were remarkable, with an approximately 10-fold increase in cyclohexane-carboxaldehyde deformylation to produce cyclohexene and formate, as shown in Fig. 2 , and an approximately 9-fold decrease in benzphetamine N-demethylation to produce norbenzphetamine and formaldehyde.
65) The former reaction was developed as a model for the demethylation reaction catalyzed by the steroidogenic P450s, aromatase and lanosterol demethylase, in which an oleˆnic product and formate are formed. [26] [27] [28] These results indicated that the suppression in the proton transfer to the active site leads to enhancement of the peroxo-Fe(III) intermediate together with the decrease of the oxo-Fe(IV)-porphyrin-p-cation radical, and that a peroxy-hemiacetal-like adduct may form between the substrate and molecular oxygenderived hydrogen peroxide. That is, the mutation caused switching between the two diŠerent oxygenating agents. Furthermore, additional experiments on oleˆn epoxidation by CYP2B4 T302A and by the corresponding mutant of the alcohol-inducible CYP2E1, CYP2E1 T303A provided evidence for the hydroperoxoFe(III) as well as the oxo-Fe(IV)-porphyrin-p-cation radical as electrophilic oxidants. 66) As proposed in Fig. 3 , such results support the concept that three distinct oxidants are functionally involved in P450-catalyzed drug oxygenations. 66) This second electrophilic oxidant, the hydroperoxo-Fe(III) intermediate, appears to react by the insertion of OH ＋ into a carbonhydrogen bond of drug to produce a protonated alcohol as theˆrst-formed metabolite. [67] [68] [69] In contrast, insertion of the oxo-Fe(IV)-porphyrin-p-cation radical produces the unprotonated alcohol directly, [67] [68] [69] which is theoretically supported by several sophisticated computational studies. [70] [71] [72] [73] 
Generation of ROS in P450-catalyzed Reaction
The reduction of molecular dioxygen not only leads to drug oxygenation, but also results in the release of ･O 2 -and H2O2, as indicated in Fig. 1 . As described above, the well-known peroxide shunt, in which H2O2 or an organic peroxy compound such as an alkyl hydroperoxide or peracid gives the oxygen atom to the drug with no requirement for O2 or NADPH as an electron donor, is also shown in Fig. 1 . 5, 13, 31, 74) Although the generation of ROS by P450 can potentially cause lipid peroxidation and cellular toxicity, [75] [76] [77] [78] whether or not the formation of ･O 2 -and H2O2 results in partly contributing to drug oxygenation remains controversial.
Recently, it was found by the ESR spin-trapping method that CYP1A2, 2B1, 2C11, and 3A4 puriˆed from rat liver induced production of ･OH and ketoconazole, an inhibitor of P450, inhibited production of ･OH in vitro. 78) When the scavenging ability of ROS is deˆcient in the biological system, ･OH and 1 O2 are suggested to simultaneously form, 79, 80) which are the most reactive species among ROS. On the other hand, we found the generation of 1 O2 in the phenobarbitalinduced rat liver microsomal system, and then, examined the possible involvement of 1 O2 in the P450 reactions.
48-50)

Contribution of Singlet Oxygen to P450-dependent Substrates Oxygenation
In order to determine the contribution of ROS generated during the P450 catalytic reaction cycle, weˆrst examined the eŠects of several radical scavengers on P450-dependent drug oxygenations in the phenobarbital-induced rat liver microsomes.
48) The addition of b-carotene, a potent quencher of 1 O2, [81] [82] [83] [84] suppressed the CYP2E1-dependent aniline p-hydroxylation 7, 85) in which aniline is known to undergo the selective p-hydroxylation as the initial metabolite by 1 O2, 87) as well astheCYP2B6-dependent7-ethoxycoumarinO-deethylation. 7, 86) No other reactive oxygen scavengers or chelating agents such as superoxide dismutase (SOD), catalase (CAT), dimethylsulfoxide (DMSO), or deferoxamine (DFO) altered the reactions, indicating that ROSs such as ･O 2 -, H2O2, and ･OH were not involved in such reactions. Because the involvement of 1 O2 in the reactions was suggested, the detection of 1 O2 was examined by the ESR spin-trapping method using 2,2,6,6-tetramethyl-4-piperidone (TMPD) as the most speciˆc trapping reagent for 1 O2 (Fig. 4) . [88] [89] [90] [91] When TMPD was added to the reaction of microsomes and NADPH, the ESR signal due to the 4-oxo-TEMPO, a TMPD-1 O2 adduct, was clearly observed (Fig. 5(A) ).
48)
When b-carotene, NaN3 as a 1 O2 quencher, 92, 93) aniline, or 7-ethoxycoumarin was added to the reaction system, all signal intensities due to 4-oxo-TEMPO were suppressed, indicating that 1 O 2 generated in the system is quenched by the addition of these compounds (Fig. 5(B)-(E) ). 48) These results demonstrated that 1 O2 appeared to function partly at least as an active oxidant species in the aniline p-hydroxylation and 7-ethoxycoumarin O-deethylation.
To extend that study, 48) we worked on providing more evidence for the involvement of 1 O2 in the P450-dependent drug oxygenations in rat and human liver microsomes. To provide this evidence, alkyl hydroxylation, aryl O-demethylation, and amine N-demethylation in rat liver microsomes and four enzyme activities in the human CYP subfamily were examined in terms of a 1 O2 quencher suppressing such reactions and by the ESR spin-trapping method. 49) Theˆndings were described as follows. (1) The CYP4A11-dependent v-and CYP2E1-dependent (v-1)-hydroxylations of lauric acid 94) were not altered by SOD, CAT, or DMSO, but signiˆcantly suppressed by NaN3 and b-carotene. (2) The nonspeciˆc CYP-dependent O-demethylation of pnitroanisole 95, 96) and N-demethylation of aminopyrine 97) were signiˆcantly suppressed by NaN3 and b-carotene. (3) P450 was conˆrmed to be stable during a reaction time of 60 min in the presence of 0.2-5 mM NaN3 or 0.1-1 mM b-carotene on the basis of the P450 levels, as estimated by the reduced P450-CO complex. 98) These results strongly indicated the involvement of 1 O2 but not of ･O 2 -, H2O2, and ･OH in the rat liver microsomal P450-dependent substrate oxidations other than the aryl hydroxylation and O-deethylation. In addition, although the ESR signal due to the DMPO-OH adduct derived from the generation of ･O 2 -and W or ･OH was detected in the rat liver microsomes-NADPH system by ESR spin-trapping using DMPO as a trapping agent, 99) the signal intensity due to the DMPO-OH adduct was not changed by the addition of substrates, emphasizing that ･O 2 -and ･OH are not likely to contribute to such drug oxygenations.
Then, the quantitative relationship between the Fig. 6 . Relationship between the O-demethylation rate of pnitroanisole and its reactivity to 1 O 2 as evaluated from the decrease of the signal intensity due to 4-oxo-TEMPO in rat liver microsomes. The reaction mixture contained 50 mM TMPD, 0.8 mg W mL microsomal protein, and 0.2-1.6 mM NADPH, with or without 0.4 mM p-nitroanisole, in a total volume of 0.5 mL of 100 mM phosphate buŠer, pH 7.4, at 379 C for 15 min. The correlation coe‹cient for the linear regression was estimated to be 0.971 for the 3 or 4 repeated experiments. (From ref. 49 ) Fig. 7 . EŠect of 1 O 2 quenchers and a spin-trapping agent on P450 enzyme activities in human liver microsomes. The reaction times were as follows: (A) 7-ethoxyresoruˆn O-deethylation as CYP1A1 W 1A2 activity for 10 min, (B) coumarin 7-hydroxylation as CYP2A6 activity for 5 min, (C) tolbutamide 4-hydroxylation as CYP2C9 activity for 30 min, and (D) nifedipine oxidation as CYP3A4 activity for 5 min. Each incubation mixture contained 0.2 mg W mL microsomal protein, and 0.5 mM 7-ethoxyresoruˆn, 50 mM coumarin, 200 mM tolbutamide, or 20 mM nifedipine in a total volume of 0.5 mL of 100 mM phosphate buŠer, pH 7.4, at 379 C, in which the reaction was initiated by the addition of an NADPH generating system (2 mM NADP＋, 10 mM G-6-P, 5 mM MgCl 2 , and 1 UW mL G-6-PDH as aˆnal concentration). The 0-5 mM NaN 3 , 0-0.5 mM b-carotene, or 0-50 mM TMPD were added to the reaction mixture. Signiˆcance: * pº0.05, ** pº0.01 vs. control (n＝3)
1 O2 in the P450 reaction pathway was examined. The signal intensity due to the TMPD-1 O2 (4-oxo-TEMPO) adduct was decreased signiˆcantly by the addition of p-nitroanisole in comparison with that without p-nitroanisole in the system, where the extent of the decrease of the signal intensity was well correlated (r＝ 0.971) with the O-demethylation rates of p-nitroanisole without TMPD (Fig. 6) , 49) indicating that p-nitroanisole utilizes 1 O2 for its demethylation. In addition, the eŠect of 1 O2 quenching on the human P450-speciˆc activities was examined. Among four P450-speciˆc activities, CYP1A1 W 1A2 activity was only aŠected by b-carotene, but other activities for CYP2A6, CYP2C9, and CYP3A4 were suppressed by NaN3, b-carotene, and TMPD (Fig. 7) . 49) Although NaN3 at a higher concentration might aŠect the binding of a type II substrate to P450 as a P450-inhibitor, 100) b-carotene as a strong quencher reacts to 1 O2 with a much higher rate constant (
. 90) These observations suggested that there are many ways in which 1 O2 contributes to human P450 activities depending on the members of the CYP subfamily.
The singlet state ( 1 Dg) of molecular oxygen ( 1 O2), which has two electrons with a paired spin in the same species bound to the heme site is predominantly generated and subsequently dissociates to the system, the species radiatively decays through either an environmental perturbation from a singlet state ( 1 Dg) to a triplet state ( 3 Sg -) or an energytransfer mechanism to the spin-allowed reaction with substrates.
104) It is known that 1 O2 can perform the P450-type oxygen insertions such as epoxidation of alkenes, oxidation of heteroatoms and of aromatics, and insertion into conformationally-hindered positions. [105] [106] [107] Therefore, it will be important to directly detect the generation of 1 O2 in the P450 catalytic cycle and to conˆrm the quantitative contribution of 1 O2 to the P450-dependent substrate reactions.
When molecular oxygen binds to the ferrous P450 with high-spin state, its 2p electrons interact with the d orbitals of the ferrous heme. Simpliˆed qualitative molecular orbital schemes for the Fe-O2 bond are shown in Fig. 8 . 102, 108) From this scheme, the Fe-O2 complexes with two discrete ground-state electronic conˆgurations are possible. When the energy separation, D, is greater than the electron-pairing energy, a Fe(II)-O2 with the spin-paired electrons is obtained, whereas in D being smaller than the pairing energy, a Fe(III)-･O2 -having two unpaired electrons is obtained, as indicated in Fig.  8 . 108) In addition, p bond formation is possible for the Fe(II)-O2 structure by back donation from a ferrous ion orbital (e.g., dxz) to the empty p * O2 orbital, and thus the Fe(II)-O2 complex has a singlet state.
5 Because the true origin of 1 O 2 in the P450 catalytic cycle is still uncertain, the question of whether 1 O2 directly contributes to P450-dependent drug oxygenations or partially participates in them, followed by generation as an intermediate in the P450 cycle, will need to be mechanistically investigated in future studies. One way to provide plausible evidence would be to directly observe the generation of 1 O2 in the microsomal P450 reactions by means of the near-infrared direct emission of 1 O2 at 1268 nm, which is the most physically reliable method. [110] [111] [112] If a sensitive near-infrared detection method of 1 O2 in the microsomal system is established, it will bring about an useful information in our understanding of the role of 1 O2 in P450-catalyzed drug oxygenation reactions.
Conclusion
Although the extent of the contribution of P450-mediated drug metabolism to the overall drug disposition and hepaticˆrst-pass eŠect is dependent on the substrate speciˆcity, it is clear that a P450-catalyzed reaction plays an important role in determining the safety and eŠectiveness of drug medication. Therefore, it is necessary to further investigate and gain a thorough understanding of the molecular mechanism on P450-dependent dioxygen activation as yet unknown catalyzed reactions. Now, a single reaction pathway in P450-catalyzed oxygenations cannot explain all of the experimental results. Increasing evidence has indicated that numerous drugs are metabolized by multiple activated oxygen species generated in the P450 catalytic cycle. An oxo-Fe(IV)-porphyrin-p-cation radical is regarded as an activated oxygen species in P450 reactions, whereas a nucleophilic Fe(III)-peroxo species has also been proposed as another oxidant. Recently, we propose that singlet oxygen ( 1 O2) is essentially involved in both rat and human liver microsomal P450 reactions. The contribution of each activated oxygen species involving the possibility of 1 O2, which is generated in the P450 catalytic cycle, to P450-dependent drug metabolism will need to be quantitatively clariˆed in the future. In addition to eŠorts to analyze the molecular structure of the mammalian P450s responsible for the substrate speciˆcity, gaining an understanding of the activated oxygen species involved in determining the type of drug metabolism will help us to predict the important (active or toxic) metabolites formed.
